RHYTHM PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Rhythm Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • Rhythm Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $267M, a 23% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $267M +$49.9M +23% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $217M +$59M +37.3% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $158M +$24.6M +18.4% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $134M +$40.7M +43.7% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $92.9M +$45.3M +94.9% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $47.7M +$23.6M +98.1% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $24.1M +$3.59M +17.5% Dec 31, 2017 10-K 2019-03-08
Q4 2016 $20.5M Dec 31, 2016 8-K 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.